Decreased vasopressin responsiveness in vasodilatory septic shock-like conditions

被引:40
|
作者
Leone, M [1 ]
Boyle, WA
机构
[1] Washington Univ, Sch Med, Crit Care Div, St Louis, MO 63130 USA
[2] Washington Univ, Sch Med, Anesthesiol Res Unit, Dept Anesthesiol, St Louis, MO USA
[3] CHU Nord, Dept Anesthesie & Reanimat, Marseille, France
关键词
vasopressin; norepinephrine; resistance artery; nitric oxide;
D O I
10.1097/01.CCM.0000206466.56669.BE
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To determine the effect of vasodilatory septic shock-like conditions on vasoconstricting responses to vasopressin and norepinephrine in isolated resistance arteries. Design: Prospective, randomized animal study. Setting. University research laboratory. Subjects: Male adult Sprague-Dawley rats. Interventions. Small mesenteric arteries (outside diameter, 50-150 mu m) were cannulated and studied in vitro under physiologic conditions. A vasodilatory septic shock-like state was produced by treatment with the nitric oxide (NO) donor, S-nitroso-N-acetylpenicillamine (SNAP), and the phosphodiesterase inhibitor, 3-isobutyl-1-methylxanthine (IBMX). Vasoconstricting concentration-response relationships were determined for norepinephrine and vasopressin before and after application of SNAP or SNAP+ IBMX. Synergism between low-dose vasopressin and norepinephrine and between low-dose norepinephrine and vasopressin was determined before and after SNAP or SNAP+lBMX. Main Results. Norepinephrine and vasopressin produced concentration-dependent contractions (half-maximal effective concentration [EC50] = 2.5 RM and 3.9 nM, respectively) that were significantly inhibited by 1 mu M SNAP (EC50 = 3.6 mu M and 8.1 nM, respectively) or 100 mu M SNAP + 10 mu M IBMX (EC50 = 10 mu M and 8.2 nM, respectively). Low-dose vasopressin significantly increased the responsiveness to norepinephrine (EC50 = 0.5 mu M just as a low-dose norepinephrine significantly enhanced the vasopressin response (EC50 = 2.3 nM). The synergistic effects of low-dose vasopressin and norepinephrine, or low-dose norepinephrine and vasopressin, were also significantly inhibited by 1 mu M SNAP (EC50 = 2.5 mu M and 4.2 nM, respectively) or 100 mu M SNAP + 10 mu M IBMX (EC50 = 9 RM and 8.4 nM, respectively). Conclusions. Vasoconstriction produced by vasopressin or norepinephrine, and the synergistic vasoconstriction produced by the combinations, was inhibited in vasodilatory septic shock-like conditions. Thus, in addition to the well-described vasopressin deficiency in vasodilatory septic shock, these studies indicate that decreased vasopressin responsiveness further contributes to a state of relative vasopressin insufficiency in this condition.
引用
收藏
页码:1126 / 1130
页数:5
相关论文
共 50 条
  • [1] The role of vasopressin in vasodilatory septic shock
    Obritsch, MD
    Bestul, DJ
    Jung, R
    Fish, DN
    MacLaren, R
    [J]. PHARMACOTHERAPY, 2004, 24 (08): : 1050 - 1063
  • [2] Arginine-vasopressin in septic and vasodilatory shock -: For
    Duenser, Martin W.
    Hasibeder, Walter R.
    Wenzel, Volker
    [J]. ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE, 2006, 41 (11-12): : 716 - 718
  • [3] Outcome of vasopressin treatment in vasodilatory septic shock
    Mann, HJ
    Beilman, GJ
    Song, JB
    Farrell, JB
    Hasinoff, IK
    Lohr, BC
    [J]. CRITICAL CARE MEDICINE, 2000, 28 (12) : A184 - A184
  • [4] Arginine vasopressin in the treatment of vasodilatory septic shock
    Holmes, Cheryl L.
    Walley, Keith R.
    [J]. BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY, 2008, 22 (02) : 275 - 286
  • [5] Vasopressin pressor hypersensitivity in vasodilatory septic shock
    Landy, DW
    Levin, HR
    Gallant, EM
    Seo, S
    DAlessandro, D
    Oz, MC
    Oliver, JA
    [J]. CRITICAL CARE MEDICINE, 1997, 25 (08) : 1279 - 1282
  • [6] A myosin phosphatase inhibitor restores vascular sensitivity in vasodilatory shock-like conditions
    Boyle, Walter A.
    Liu, Hung-Pin
    Garcia-Ferrer, Josephine
    [J]. CRITICAL CARE MEDICINE, 2007, 35 (12) : A4 - A4
  • [7] HYPERSENSITIVITY TO THE PRESSOR EFFECT OF VASOPRESSIN IN VASODILATORY SEPTIC SHOCK
    LANDRY, DW
    LEVIN, HR
    SEO, S
    GALLANT, EM
    DALLESANDRO, DA
    OZ, MC
    OLIVER, JA
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 469 - 469
  • [8] Vasopressin (AVP) deficiency in vasodilatory septic shock (VDSS).
    Landry, D
    Levin, H
    Oz, M
    Oliver, JA
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A1586 - A1586
  • [9] Arginine-vasopressin in septic and vasodilatory shock - Against
    Meier-Hellmann, Andreas
    [J]. ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE, 2006, 41 (11-12): : 719 - 719
  • [10] The effects of vasopressin on severe vasodilatory septic shock patients
    Nakano, Y
    Yamada, H
    Kakihana, Y
    Nakamura, M
    Hashiguchi, H
    [J]. ANESTHESIOLOGY, 1999, 91 (3A) : U200 - U200